Apo-Haloperidol en es it fr

Apo-Haloperidol Brand names, Apo-Haloperidol Analogs

Apo-Haloperidol Brand Names Mixture

  • No information avaliable

Apo-Haloperidol Chemical_Formula


Apo-Haloperidol RX_link


Apo-Haloperidol fda sheet

Apo-Haloperidol FDA

Apo-Haloperidol msds (material safety sheet)

Apo-Haloperidol MSDS

Apo-Haloperidol Synthesis Reference

P. A. J. Janssen, Belg. pat. 577,977 (1959), C.A. 54, 4630c (1960); idem, Brit. pat. 895,309 corresp to U.S. pat. 3,438,991 (1962, 1969 to Janssen).

Apo-Haloperidol Molecular Weight

375.864 g/mol

Apo-Haloperidol Melting Point

151.5 oC

Apo-Haloperidol H2O Solubility

14 mg/L

Apo-Haloperidol State


Apo-Haloperidol LogP


Apo-Haloperidol Dosage Forms

Injection; Oral solution; Tablet

Apo-Haloperidol Indication

For the treatment of schizophrenic patients who require prolonged parenteral antipsychotic therapy also used in Tourette's syndrome and Severe hyperactivity.

Apo-Haloperidol Pharmacology

Haloperidol is a psychotropic agent indicated for the treatment of schizophrenia. It also exerts sedative and antiemetic activity. Haloperidol has actions at all levels of the central nervous system-primarily at subcortical levels-as well as on multiple organ systems. Haloperidol has strong antiadrenergic and weaker peripheral anticholinergic activity; ganglionic blocking action is relatively slight. It also possesses slight antihistaminic and antiserotonin activity.

Apo-Haloperidol Absorption


Apo-Haloperidol side effects and Toxicity

LD50=165 mg/kg (rats, oral)

Apo-Haloperidol Patient Information


Apo-Haloperidol Organisms Affected

Humans and other mammals